The Application dimension of the Coronary Artery CT Fractional Flow Reserve Calculation Software market is divided into three principal use‑cases: Diagnostic Evaluation, Treatment Planning, and Clinical Research. Diagnostic Evaluation encompasses software deployed for routine assessment of coronary lesions, directly influencing the bulk of software licences due to its high procedural volume; it therefore accounts for the largest share of market revenue. Treatment Planning refers to tools that integrate FFR‑CT outputs with interventional strategies, such as percutaneous coronary intervention (PCI) simulation, and contributes a substantial secondary revenue stream driven by hospitals seeking to reduce invasive procedures. Clinical Research includes applications supporting trial design, data analytics, and outcome studies, representing a niche yet growing segment as academic institutions expand non‑invasive functional testing. Collectively, these applications shape the overall market size by allocating resources according to procedural frequency and value‑added services, a core element of Coronary Artery CT Fractional Flow Reserve Calculation Software segmentation.